[go: up one dir, main page]

NO20063483L - Therapeutic combinations - Google Patents

Therapeutic combinations

Info

Publication number
NO20063483L
NO20063483L NO20063483A NO20063483A NO20063483L NO 20063483 L NO20063483 L NO 20063483L NO 20063483 A NO20063483 A NO 20063483A NO 20063483 A NO20063483 A NO 20063483A NO 20063483 L NO20063483 L NO 20063483L
Authority
NO
Norway
Prior art keywords
mammal
therapeutic combinations
inhibitors
administering
treating
Prior art date
Application number
NO20063483A
Other languages
English (en)
Norwegian (no)
Inventor
Amy Karen Patick
Jennifer Lou Hammond
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20063483L publication Critical patent/NO20063483L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20063483A 2004-01-30 2006-07-31 Therapeutic combinations NO20063483L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54074904P 2004-01-30 2004-01-30
US61500004P 2004-10-01 2004-10-01
PCT/IB2005/000101 WO2005082362A1 (fr) 2004-01-30 2005-01-17 Combinaisons therapeutiques

Publications (1)

Publication Number Publication Date
NO20063483L true NO20063483L (no) 2006-08-30

Family

ID=34915540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063483A NO20063483L (no) 2004-01-30 2006-07-31 Therapeutic combinations

Country Status (12)

Country Link
US (1) US20050171038A1 (fr)
EP (1) EP1713470A1 (fr)
JP (1) JP2007519704A (fr)
KR (1) KR20060114374A (fr)
AU (1) AU2005216710A1 (fr)
BR (1) BRPI0506493A (fr)
CA (1) CA2555171A1 (fr)
IL (1) IL177155A0 (fr)
MX (1) MXPA06008632A (fr)
NO (1) NO20063483L (fr)
RU (1) RU2006128606A (fr)
WO (1) WO2005082362A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266579A1 (fr) * 2004-10-19 2010-12-29 Achillion Pharmaceuticals, Inc. Composition pharmaceutique comprenant elvucitabine
US20080194554A1 (en) * 2005-03-11 2008-08-14 Mclean Ed W Hiv Protease Inhibitors
WO2007033208A2 (fr) * 2005-09-12 2007-03-22 University Of Maryland Biotechnology Institute Off. Of Research Admin/Tech. Dev. Utilisation d’indirubine et de ses dérivés dans les traitements d’une infection par le vih et d’insuffisance cardiaque
FR2892719B3 (fr) * 2005-11-02 2008-01-18 Sep Innovaterm Barriere physico-chimique anti-termites constituee par du beton dans lequel a ete incorpore dans toute la masse un insecticide contre les termites
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
EP1988776B1 (fr) * 2006-03-02 2012-08-08 Siga Technologies, Inc. Médicaments antiviraux pour le traitement d'une infection à arénavirus
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
CA2657821A1 (fr) * 2006-07-21 2008-01-24 Gilead Sciences, Inc. Inhibiteurs de la aza-peptide-protease
WO2008078200A2 (fr) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Inhibiteurs de la protéase
US20140315936A1 (en) * 2011-11-18 2014-10-23 Avexa Limited Apricitabine and pi combination therapy
CN105669749B (zh) * 2014-08-14 2018-03-30 赫斯（西安）生物科技有限公司 抗病毒药物及组合物
EP3645029B1 (fr) * 2017-06-26 2023-01-18 Institut Pasteur Traitements pour éliminer des réservoirs de vih et réduire la charge virale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
IL177155A0 (en) 2008-04-13
KR20060114374A (ko) 2006-11-06
WO2005082362A1 (fr) 2005-09-09
JP2007519704A (ja) 2007-07-19
MXPA06008632A (es) 2006-09-04
EP1713470A1 (fr) 2006-10-25
RU2006128606A (ru) 2008-03-10
US20050171038A1 (en) 2005-08-04
CA2555171A1 (fr) 2005-09-09
BRPI0506493A (pt) 2007-02-13
AU2005216710A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
EP1406622A4 (fr) Inhibiteurs de dipeptidyl peptidase utilises dans le traitement du diabete
EA200870380A1 (ru) Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
NO20083216L (no) Myke proteaseinhibitorer og pro-myke former derav
BR0315796A (pt) Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
EP1406872A4 (fr) Inhibiteurs de dipeptidyle peptidase pour le traitement du diabete
EA200801538A1 (ru) Лечение диабета 2 типа комбинацией ингибитора дипептидилпептидазы iv (dpiv) и метформина или тиазолидиндиона
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
NO20064307L (no) Inhibitorer av dipeptidylpeptidase IV for regulering av glukose metabolisme
DK1556362T3 (da) Heterocykliske beta-aminodipeptidylpeptidaseinhibitorer til behandling eller forebyggelse af diabetes
EA201001523A1 (ru) Ингибиторы матриксной металлопротеазы на основе арилсульфонамида
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20080150L (no) Inhibitorer av AKT-aktivitet
EA200800670A1 (ru) Ингибиторы сериновых протеаз
BR0009167A (pt) Inibidores de enzima impdh
NO20063483L (no) Therapeutic combinations
WO2008106058A3 (fr) Inhibiteurs de sérine protéases
NO20080785L (no) Behandling av kreft
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
NO20075973L (no) Dipeptidyl-peptidase-IV-inhibitorer
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20083885L (no) Fremgangsmate for behandling av inflammatoriske sykdommer
NO20083032L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse
WO2007117482A3 (fr) Inhibiteurs de la rénine
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
NO20091353L (no) Serine hydrolaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application